期刊文献+

Survivin antisense oligodeoxynucleotide inhibits growth of gastric cancer cells 被引量:23

Survivin antisense oligodeoxynucleotide inhibits growth of gastric cancer cells
下载PDF
导出
摘要 AIM:To investigate the effect of transfected survivin antisense oligonucleotide (ASODN) on proliferation and apoptosis of gastric cancer ceils. METHODS:The authors designed ASODNs targeting different regions of survMn mRNA,including surviving ASODN1,ASODN2 and ASODN3.ASODNs were transfected into gastric cancer cell line SGC 7901,cell growth was detected by MTT assay.Cells exposed to the potent oligonucleotide were also examined for apoptosis induction by FCM and fluorescence microscopy.Semiquantitive RT-PCR and Western blot examinations were carried for expression of survivin mRNA and protein. RESULTS:ASODN3 caused a statistically significant reduction of cell viability to 60.6% (±2.9%) (P<0.01),while ASODN1 and ASODN2 had no such changes (P>0.05).The cell growth was also significantly inhibited by ASODN3, compared with reversal and scrambled sequence.A significant loss of survivin mRNA was presented in ASODN3 treated ceils and this was not seen in treatment with sense ODN or scramble ODN.Protein level was significantly decreased 48 h after survivin ASODN trasfected by approximately 2-fold decrease comparedwith untreated controls.However. ASODN3 did not induce significant apoptosis response until 48 h after transfection (P>0.05). CONCLUSION:ASODN3,which targets translation initiation part,can be identified as a most potent antisense compound. Srvivin ASODN3 may provide a novel approach to therapy of gastric cancer. To investigate the effect of transfected survivin antisense oligonucleotide (ASODN) on proliferation and apoptosis ofgastric cancer cells.
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2004年第8期1121-1124,共4页 世界胃肠病学杂志(英文版)
基金 Supported by Shanghai Key Research Project Grant in Medical Science Development (99ZD003)
  • 相关文献

参考文献31

  • 1Reed JC. Dysregulation of apoptosis in cancer. J Clin Oncol 1999; 17:2941-2953.
  • 2Deveraux QL, Reed JC. lAP family proteins-suppressors of apoptosis. Genes Dev 1999; 13:239-252.
  • 3Ambrosini G, Adida C, Altieri DC. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 1997; 3:917-921.
  • 4Altieri DC, Marchisio PC, Marchisio C. Survivin apoptosis: an interloper between cell death and cell proliferation in cancer.Lab Invest 1999; 79:1327-1333.
  • 5Lu CD, Altieri DC, Tanigawa N. Expression of a novel antiapoptosis gene, survivin, correlated with tumor cell apoptosis and p53 accumulation in gastric carcinomas. CancerRes 1998; 58:1808-1812.
  • 6Nicholson DW. From bench to clinic with apoptosis-based therapeutic agents. Nature 2000; 407:810-816.
  • 7Ziegler A, Luedke GH, Fabbro D, Altmann KH, Stahel RA,Zangemeister-Wittke U. Induction of apoptosis in small-cell lung cancer cells by an antisense oligodeoxynucleotide targeting the Bcl-2 coding sequence. J Natl Cancer Inst 1997; 89:1027-1036.
  • 8Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162:156-159.
  • 9Yuen AR, Sikic BI. Clinical studies of antisense therapy in cancer. Front Biosci 2000; 5:D588-593.
  • 10Jansen B, Wacheck V, Heere-Ress E, Schlagbauer-Wadl H,Hoeller C, Lucas T, Hoermann M, Hollenstein U, Wolff K,Pehamberger H. Chemosensitisation of malignant melanoma by BCL2 antisense therapy. Lancet 2000; 356:1728-1733.

同被引文献86

引证文献23

二级引证文献137

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部